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Background:  Definitive diagnosis for cardiac device infection (CDI) is often challenging. Since extraction is associated with significant morbidity 
and mortality, new imaging modalities to confirm the infectious process and its dissemination would be of clinical value. Combined 18F-FDG 
positron emission tomography and computed tomography (18F-FDG PET/CT) is well established in oncology, cardiology and neurology, but has not 
been properly evaluated for the investigation of CDI.
Methods:  Two groups of consecutive patients were compared. In group 1, 24 patients (18 men, 67±16 years, EF 40±17%) with suspected CDI 
underwent 18F-FDG PET/CT. Group 2 comprised 11 patients (9 men, 70±11 years, EF 50±8%) with implanted devices for at least 6 months without 
any sign of CDI who underwent 18F-FDG PET/CT for another indication. Attenuation-corrected as well as non-corrected images were reviewed. Results 
were correlated with clinical data.
Results:  In group 1, 17/24 patients (71%) with suspected CDI had a positive 18F-FDG PET/CT with a SUV of 4.4±1.8. There was no abnormal 
uptake (p<0.001) in any of group 2 patients. Abnormal 18F-FDG uptake was visualised on the leads (n=13), in the pocket (n=13), in the 
subcutaneous tissue (n=4) and within the heart (n=1). Eleven patients had a TEE and vegetations were suspected in 7 patients; in 5 of these 
patients, 18F-FDG uptake was increased in the same anatomical site. Fourteen patients with positive 18F-FDG PET/CT underwent extraction. 
Excellent correlation was obtained in all patients between 18F-FDG uptake result and findings during extraction. Seven patients in group 1 with 
negative 18F-FDG PET/CT were treated with antibiotics only and none has relapsed at 5.2±2.5 months.
Conclusion: 18F-FDG PET/CT is a useful new diagnostic modality in the investigation of CDI. The absence of abnormal uptake among 
asymptomatic patients implanted with pacemaker/defibrillator for at least 6 months suggest that there is no long-term uptake post implant, hence 
low risk of false positive after such time. The exact localisation as well as extent of uptake on 18F-FDG PET/CT correlated well with TEE and extraction 
findings. This imaging modality may help in the choice of appropriate treatment.
